Adherence to clinic recommendations among patients with phenylketonuria in the United States

被引:129
作者
Jurecki, E. R. [1 ]
Cederbaum, S. [2 ,3 ]
Kopesky, J. [4 ,5 ]
Perry, K. [6 ]
Rohr, F. [7 ]
Sanchez-Valle, A. [8 ]
Viau, K. S. [9 ]
Sheinin, M. Y. [6 ]
Cohen-Pfeffer, J. L. [1 ]
机构
[1] BioMarin Pharmaceut Inc, Med Affairs, Novato, CA 94949 USA
[2] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Dept Pediat & Human Genet, Los Angeles, CA USA
[4] Childrens Hosp Wisconsin, Dept Clin Nutr, Milwaukee, WI 53201 USA
[5] Childrens Hosp Wisconsin, Dept Genet, Milwaukee, WI 53201 USA
[6] Trinity Partners, Waltham, MA USA
[7] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA
[8] Univ S Florida, Div Genet & Metab, Tampa, FL USA
[9] Univ Utah, Dept Pediat, Div Med Genet, Salt Lake City, UT USA
关键词
Phenylketonuria; Adherence; Blood phenylalanine; ACMG guidelines; Adults; PHENYLALANINE-HYDROXYLASE DEFICIENCY; MANAGEMENT; PKU; COUNTRIES; ISSUES; ACCESS;
D O I
10.1016/j.ymgme.2017.01.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Assess current management practices of phenylketonuria (PKU) clinics across the United States (US) based on the key treatment metrics of blood phenylalanine (Phe) concentrations and blood Phe testing frequency, as well as patient adherence to their clinic's management practice recommendations. Methods: An online survey was conducted with medical professionals from PKU clinics across the US from July to September 2015. Forty-four clinics participated in the survey and account for approximately half of PKU patients currently followed in clinics in the US (Berry et al., 2013). Results: The majority of PKU clinics recommended target blood Phe concentrations to be between 120 and 360 mu M for all patients; the upper threshold was relaxed by some clinics for adult patients (from 360 to 600 mu M) and tightened for patients who are pregnant/planning to become pregnant (to 240 mu M). Patient adherence to these recommendations (percentage of patients with blood Phe below the upper recommended threshold) was age-dependent, decreasing from 88% in the 0-4 years age group to 33% in adults 30 + years. Patient adherence to recommendations for blood testing frequency followed a similar trend. Higher staffing intensity (specialists per 100 PKU patients) was associated with better patient adherence to clinics' blood Phe concentrations recommendations. Conclusion: Clinic recommendations of target blood Phe concentrations in the US are now stricter compared to prior years, and largely reflect recent guidelines by the American College of Medical Genetics and Genomics (Vockley et al., 2014). Adherence to recommended Phe concentrations remains suboptimal, especially in older patients. However, despite remaining above the guidelines, actual blood Phe concentrations in adolescents and adults are lower than those reported in the past (Walter et al., 2002; Freehauf et al., 2013). Continued education and support for PKU patients by healthcare professionals, including adequate clinic staffing, are needed to improve adherence. Future research is needed to understand how to improve adherence to reduce the number of patients lost to follow-up, as the findings of this and similar surveys do not address how to keep patients in clinic. (C) 2017 The Authors. Published by Elsevier Inc.
引用
收藏
页码:190 / 197
页数:8
相关论文
共 21 条
[1]  
Agency for Healthcare Research and Quality (AHRQ). Adjuvant Treatment for Phenylketonuria (PKU), 2012, COMP EFF REV, V56
[2]   Blood phenylalanine control in phenylketonuria: a survey of 10 European centres [J].
Ahring, K. ;
Belanger-Quintana, A. ;
Dokoupil, K. ;
Gokmen-Ozel, H. ;
Lammardo, A. M. ;
MacDonald, A. ;
Motzfeldt, K. ;
Nowacka, M. ;
Robert, M. ;
van Rijn, M. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2011, 65 (02) :275-278
[3]   Phenylketonuria: a review of current and future treatments [J].
Al Hafid, Naz ;
Christodoulou, John .
TRANSLATIONAL PEDIATRICS, 2015, 4 (04) :304-317
[4]   Newborn screening 50 years later: access issues faced by adults with PKU [J].
Berry, Susan A. ;
Brown, Christine ;
Grant, Mitzie ;
Greene, Carol L. ;
Jurecki, Elaina ;
Koch, Jean ;
Moseley, Kathryn ;
Suter, Ruth ;
van Calcar, Sandra C. ;
Wiles, Judy ;
Cederbaum, Stephen .
GENETICS IN MEDICINE, 2013, 15 (08) :591-599
[5]   Management of phenylketonuria in Europe: Survey results from 19 countries [J].
Blau, Nenad ;
Belanger-Quintana, Amaya ;
Demirkol, Muebeccel ;
Feillet, Francois ;
Giovannini, Marcello ;
MacDonald, Anita ;
Trefz, Friedrich K. ;
van Spronsen, Francjan .
MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) :109-115
[6]  
Bowersox J, 2001, PEDIATRICS, V108, P972
[7]   Phenylketonuria (PKU): A problem solved? [J].
Brown, Christine S. ;
Lichter-Konecki, Uta .
MOLECULAR GENETICS AND METABOLISM REPORTS, 2016, 6 :8-12
[8]   Impact of geographic access to care on compliance and metabolic control in phenylketonuria [J].
Freehauf, Cynthia ;
Van Hove, Johan L. K. ;
Gao, Dexiang ;
Bernstein, Laurie ;
Thomas, Janet A. .
MOLECULAR GENETICS AND METABOLISM, 2013, 108 (01) :13-17
[9]   Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results [J].
Gizewska, Maria ;
MacDonald, Anita ;
Belanger-Quintana, Amaya ;
Burlina, Alberto ;
Cleary, Maureen ;
Coskun, Turgay ;
Feillet, Francois ;
Muntau, Ania C. ;
Trefz, Friedrich K. ;
van Spronsen, Francjan J. ;
Blau, Nenad .
EUROPEAN JOURNAL OF PEDIATRICS, 2016, 175 (02) :261-272
[10]  
GMDI, 2016, GEN MET DIET INT PKU